Ellen AB (ELN) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 10 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.14

Return on Equity

-169.99%

Price to Book

2.93

Revenue and Profits:

Net Sales:

2 Million

(Quarterly Results - Dec 2013)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-30.0%

6 Months

13.24%

1 Year

-29.36%

2 Years

-15.38%

3 Years

-69.36%

4 Years

-82.2%

5 Years

-85.59%

Ellen AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

18.62%

EBIT Growth (5y)

6.88%

EBIT to Interest (avg)

-7.36

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.53

Sales to Capital Employed (avg)

3.04

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.19

EV to EBIT

-1.55

EV to EBITDA

-1.65

EV to Capital Employed

3.55

EV to Sales

0.63

PEG Ratio

Dividend Yield

ROCE (Latest)

-229.49%

ROE (Latest)

-169.99%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is -66.15% vs 51.16% in Dec 2012",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is -633.33% vs 88.89% in Dec 2012",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'13",
        "Dec'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.20",
          "val2": "6.50",
          "chgp": "-66.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.40",
          "val2": "-0.50",
          "chgp": "-380.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.20",
          "val2": "-0.30",
          "chgp": "-633.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,155.30%",
          "val2": "-104.80%",
          "chgp": "-105.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -11.72% vs 7.11% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 60.00% vs 37.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.60",
          "val2": "25.60",
          "chgp": "-11.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.60",
          "val2": "-3.70",
          "chgp": "-24.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-3.00",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-204.80%",
          "val2": "-145.40%",
          "chgp": "-5.94%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY

Dec'13

Dec'12

Change(%)

Net Sales

2.20

6.50

-66.15%

Operating Profit (PBDIT) excl Other Income

-2.40

-0.50

-380.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-2.20

-0.30

-633.33%

Operating Profit Margin (Excl OI)

-1,155.30%

-104.80%

-105.05%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2013 is -66.15% vs 51.16% in Dec 2012

Consolidated Net Profit

YoY Growth in quarter ended Dec 2013 is -633.33% vs 88.89% in Dec 2012

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

22.60

25.60

-11.72%

Operating Profit (PBDIT) excl Other Income

-4.60

-3.70

-24.32%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.20

-3.00

60.00%

Operating Profit Margin (Excl OI)

-204.80%

-145.40%

-5.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -11.72% vs 7.11% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 60.00% vs 37.50% in Dec 2023

All Annual Results

Company CV

About Ellen AB

Ellen AB

Pharmaceuticals & Biotechnology

Ellen AB is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Company’s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others. As of December 31, 2011, the Company had two subsidiaries, including the wholly owned Ellen Australia pty LTD and the 70%-owned Ellen Asia LTD. As of December 31, 2011, its largest shareholder was Banque Ohman S.A. (18.73%). On July 3, 2013, it launched an online store, www.ellen.se, where customers can search for products' information and shop online.

Company Coordinates

Company Details

Barnhusgatan 4 og bv , STOCKHOLM None : 111 23

Tel: 46 8 4121000

http://www.ellenab.se

Registrar Details